Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. - Wikidata - wikimedia - TriplyDB

Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.

Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.

http://www.wikidata.org/entity/Q33784839

about

The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation Use of genetically-engineered pig donors in islet transplantation Kidney xenotransplantation Clinical lung xenotransplantation--what donor genetic modifications may be necessary?The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetes Immune modulation in xenotransplantation New insights into the regulation of inflammation by adenosine.Coagulation dysregulation as a barrier to xenotransplantation in the primate Controlling coagulation dysregulation in xenotransplantation.Immunobiology of liver xenotransplantation.Adenosine: an old drug newly discovered.Overcoming the barriers to xenotransplantation: prospects for the future Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient mice Partial netrin-1 deficiency aggravates acute kidney injury CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation.Histopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejection Cellular function and molecular structure of ecto-nucleotidases.Pig-to-monkey islet xenotransplantation using multi-transgenic pigs.Current status of animal-to-human transplantation.The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons Glucose metabolism in pigs expressing human genes under an insulin promoter.Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury.P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions.Impaired natriuretic response to high-NaCl diet plus aldosterone infusion in mice overexpressing human CD39, an ectonucleotidase (NTPDase1).In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.Simultaneous Overexpression of Functional Human HO-1, E5NT and ENTPD1 Protects Murine Fibroblasts against TNF-α-Induced Injury In Vitro CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia Transgenic swine: expression of human CD39 protects against myocardial injury.Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities Defective renal water handling in transgenic mice over-expressing human CD39/NTPDase1 Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantation Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.Current progress in xenogeneic tolerance.Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?Which anti-platelet therapies might be beneficial in xenotransplantation?The calcium activated nucleotidases: A diverse family of soluble and membrane associated nucleotide hydrolyzing enzymes.Xenotransplantation as a model of integrated, multidisciplinary research

P2860

Q21131166-C9BF03DB-E7F3-40AA-BB81-AD3B10227548 Q26771395-62CEB48A-1F78-42EC-B944-5703CADDC042 Q26822638-EE9FFAFB-3411-4BBE-9081-32C03D04F2DE Q26823663-B8BA4661-7C4E-4929-BE9C-0716BE86C5BF Q26825668-2C788005-C896-4B89-962E-AFDA1D8542E5 Q26826905-D7B5DB6A-A39C-432F-93AA-74EEDE480F75 Q30440914-42E45715-967A-44FA-A946-FD05D72C346A Q33381973-18EBB436-64B6-46B3-85DD-F4FAFF46D635 Q33394542-7FBBD2DF-6C4D-4ED6-98FB-207D49F8C506 Q33403888-64BD4BA3-849D-4108-852E-189312C840FF Q33555006-77FAF9FA-5CC5-4AB0-BC76-9F3CD2C26B01 Q33801035-C42E9F2E-26BC-4416-84B8-42004468FA7D Q33867669-F3FEB688-D959-4567-A733-771ED83A5560 Q33916670-B92584D1-DEFE-4EA6-98EE-1E352B7E994D Q33917557-DC521072-03AD-451E-B1D9-A212EFB42173 Q34018912-749C01C9-6536-4138-8536-973B4FCD2C09 Q34031794-44E7FFA9-E554-49B1-A916-124D5D6320C0 Q34041999-1F6851BA-94DE-4A6B-ACDC-BB430E2701C0 Q34665240-3E3BB597-D5C0-4BB7-9C46-507E096BD3A4 Q34769236-B6892954-2D6B-4947-ADE3-09550B00ED36 Q35012361-5C0C0B0D-A1C7-4407-97E9-F5BFE42FDDD9 Q35085119-00B4D462-CEDC-4FDE-8038-38502498F476 Q35574518-78B03D81-3B91-4EDC-BDF5-7DF5DAF49E3D Q35632965-98E17F8D-DB15-4FC7-89AB-B8D506899C0C Q35636842-E0847C90-0008-454E-84B1-4846CF1B9595 Q35749648-88813961-833A-436A-82E9-765BA8DA637E Q35779631-5CEB6E9C-010F-4E8D-81FE-5D4E2A69E5B6 Q35826059-FEE63841-7DCA-4B37-A4AD-537FFABA09CD Q35828073-5B9F3743-C1FD-432B-8DD7-52C1E05160BA Q35892406-7CF6D014-6D9E-404D-951F-6F6EB982844F Q36071796-829CD7C7-7491-47BA-8426-D608B81B210A Q36183732-3F4016E7-41A4-4BA5-B7DC-CCC871D89EF5 Q36208891-35FEA537-5FC3-47CB-9B6A-522160128972 Q36350059-A000F74C-E6BE-47EB-9F80-E4D28A80283D Q36357191-B0031BD5-F2B4-4540-A0F4-F86DD8DF8151 Q36692524-C9DDE636-CE73-4CD5-ABBB-6A7102261D3A Q36779378-9318D768-6D21-4BFF-B1FD-1B07D3E6D890 Q37069089-DC289A57-E828-4963-9635-AF9C159E834B Q37135540-9072B5B3-4BA6-4149-A3AB-7E2C99D9715C Q37137178-AE23FF21-0C3B-4412-A58C-86695B5888DF

P2860

Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.

http://www.wikidata.org/entity/Q33784839

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Thromboregulatory manifestatio ...... c disease and transplantation.

@ast

Thromboregulatory manifestatio ...... c disease and transplantation.

@en

type

label

Thromboregulatory manifestatio ...... c disease and transplantation.

@ast

Thromboregulatory manifestatio ...... c disease and transplantation.

@en

prefLabel

Thromboregulatory manifestatio ...... c disease and transplantation.

@ast

Thromboregulatory manifestatio ...... c disease and transplantation.

@en

P1433

Q33784839-13894050-5AD7-4AD2-9D3A-859FC282A33B

P1476

Q33784839-CB1D2DCD-7CA3-4F88-B55A-9EF6BE64DB17

P2093

Q33784839-151F6DE7-D9EE-4A25-B441-5216461045D8

Q33784839-2A994BB6-500C-4A97-9105-DEBE48A3A307

Q33784839-34B45C57-13D9-495D-A830-7353D49B921A

Q33784839-39567B46-E9A6-4420-9493-FA7A41D56A75

Q33784839-4BE27D8D-E74C-4AD6-9A0E-57927E79DE27

Q33784839-798C3342-5CD5-4E37-A48C-4DAF50A7BDA9

Q33784839-85D1EB49-4FC3-4AF4-88D3-E7148B6BE82F

Q33784839-8DB9A500-46ED-454D-9C7A-E42F0AD64C36

Q33784839-986E46F2-1596-46B6-AD3D-C52E32884792

Q33784839-BECB8C2E-1C48-4980-939C-76E7AEEC2D7A

P2860

Q33784839-026FC733-68B6-4F8C-AA23-71023A98DEA3

Q33784839-1136FF27-54CE-4790-936F-10B84AFDD3DE

Q33784839-1716D07E-F106-4B07-BD5E-83C59B57B611

Q33784839-1A976DFB-BBE4-4E2E-A34F-35597B7786E7

Q33784839-1B3D3D48-D816-499E-B62C-8D2C96ACAAA9

Q33784839-2151A8D0-014F-43BB-8F96-01A277A91672

Q33784839-229B086E-79FF-41D0-A818-E90C7E92F19B

Q33784839-275CFCEA-8F37-4733-A91D-6382A23C4EFF

Q33784839-322BB40D-A508-401E-BF4B-7DBBBA683303

Q33784839-38284B91-D603-45CD-9942-3A1A43B476EC

P304

Q33784839-3EC5140D-E4C1-4488-9CDD-C5205CE2BADA

P31

Q33784839-F4D9F27A-1A6D-4991-94F2-F1B38750CC25

P356

Q33784839-88B2C538-F445-48DB-9179-49D9114269B9

P407

Q33784839-1AF4F568-CBC1-4079-88A9-B3D4F7ADBD48

P433

Q33784839-7263DEBA-F4DC-4B4F-ACE8-80B78837323E

P478

Q33784839-5614CEE5-380C-4290-A100-8ACB88BFF987

P577

Q33784839-2B0B5013-0E64-4634-8D0D-AA8F4D623651

P698

Q33784839-88B27EBD-FB92-4C9B-975A-9F92FD5BF3E9

P932

Q33784839-E83815F5-9CCC-4ECF-8DB3-09C35625A57D

P356

P1433

Journal of Clinical Investigation

P1476

Thromboregulatory manifestatio ...... c disease and transplantation.

@en

P2093

Anthony J F d'Apice

http://www.w3.org/2001/XMLSchema#string

Duncan J Campbell

http://www.w3.org/2001/XMLSchema#string

Elzbieta Kaczmarek

http://www.w3.org/2001/XMLSchema#string

Harshal H Nandurkar

http://www.w3.org/2001/XMLSchema#string

Hilton Gock

http://www.w3.org/2001/XMLSchema#string

Karen M Dwyer

http://www.w3.org/2001/XMLSchema#string

Lisa J Murray-Segal

http://www.w3.org/2001/XMLSchema#string

Nella Fisicaro

http://www.w3.org/2001/XMLSchema#string

Peter J Cowan

http://www.w3.org/2001/XMLSchema#string

Simon C Robson

http://www.w3.org/2001/XMLSchema#string

P2860

The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization

Identification and characterization of CD39/vascular ATP diphosphohydrolase

A physiological role of the adenosine A3 receptor: sustained cardioprotection

Loss of ATP diphosphohydrolase activity with endothelial cell activation

CD39 modulates endothelial cell activation and apoptosis

Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain

5'-Nucleotidase: molecular structure and functional aspects

Role of endogenous adenosine as a modulator of syncope induced during tilt testing.

Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons.

Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates.

P304

1440-1446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI19560

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15146241

http://www.w3.org/2001/XMLSchema#string

P932

406523

http://www.w3.org/2001/XMLSchema#string